Introduction
Site-directed mutagenesis (SDM) allows DNA modifications by extending oligonucleotide primers which contain the desired mutation(s) flanked by bases complementary to target sequences (1) . Several protocols exist in which PCRand non-PCR-based methods are used (2) (3) (4) (5) (6) (7) (8) . However, SDM is restrained by the fidelity and template size limitations of in vitro DNA synthesis and the success rate for mutagenesis decreases with the number of mismatches introduced by the mutagnenic primer(s). Hence, an amplicon size-independent method with a broad mutational spectrum would be very useful.
Red/ET recombination has come to be recognized as superior technology for the size and sequence independent manipulation of DNA in Escherichia coli (reviewed in Reference 9) . The phage λ-derived technology relies on ssDNA or dsDNA fragments with ∼50-base tails homologous to the target region. No specific recombination sites are required and homology tails of any sequence can easily be integrated into synthetic oligos either used to PCR-amplify dsDNA flanked by homology or for oligonucleotide-directed recombination. Oligonucleotides complementary to the replicon's lagging strand recombine most efficiently (see Reference 9 and references therein). The Red/ET machinery is composed of exonuclease Redα, which processes linear dsDNA and provides 3′ ss overhangs, and Redβ, which mediates strand annealing and exchange reactions starting from ssDNA extremities. To stabilize dsDNA substrates in the cell, Red/ET recombination is assisted by Redγ, an inhibitor of the host ExoV (see Reference 9 and references therein). For ease of stringent expression control and transfer between strains, we fused the red genes to the arabinose-inducible pBAD promoter on thermoreplicative plasmid pRed/ET, which is maintained at ∼30°C and lost at temperatures ≥37°C (10) .
In genetically stable E. coli cells, the recombineering efficiency is ∼10 -4 for dsDNA [e.g., drug resistance (drug R ) cassettes and ∼10 -3 for oligonucleotides complementary to the replicon's lagging strand] (9). Hence, laborious colony screening is required to detect such an event. Counter-selectable (CS) cassettes have been successfully used in single copy replicons to select for seamless mutants that have undergone recombination leading to its loss (11) (12) (13) (14) . However, recombineering (recombination-mediated genetic engineering) in a multiple-copy situation results in a mixture of mutated and parental plasmids (15) , and phenotypic CS markers are not reliably applicable because a CS gene on a single parental plasmid copy can be sufficient for cell death. In addition, plasmid recombineering facilitates the formation of multimers (15) (16) (17) . Co-electroporation of modifying linear DNA and substrate plasmids into Red/ET proficient cells was shown to minimize, but not to eliminate, the formation of higherweight species (15) (16) (17) .
Here we report a method based on recombineering and unique restriction site elimination (USE), which allows for the efficient and extensive modification of plasmids regardless of size or sequence requirements. drug R cassettes were PCR-amplified with primers attaching (i) linearization sites (LS) absent in the substrate plasmids, and (ii) specific 50-bp target flanks for recombination. Substrate plasmids and drug R -LS cassettes were co-electroporated in Red/ET-proficient E. coli cells. Upon isolation of recombinant plasmids, modifying ssDNA and dsDNA was used to replace the drug R -LS cassettes in a second recombineering step, rendering the mutated plasmids immune to cleavage by USE. Following selective in vitro digestion of parental plasmids and retransformation, a ∼38% mutation efficiency was achieved for target plasmids of ≤13 kb.
Materials and methods
E. coli strain and culture conditions E. coli HS996 (Table 1) was aerobically propagated on Luria-Bertani (LB) broth and agar. As necessary, ampicillin (Ap), chloramphenicol (Cm), kanamycin (Km), Site-directed mutagenesis of multi-copy-number plasmids: Red/ET recombination and unique restriction site elimination
Existing methods for site-directed plasmid mutagenesis are restrained by the small spectrum of modifications that can be introduced by mutagenic primers and the amplicon size limitations of in vitro DNA synthesis. As demonstrated here, the combined use of Red/ET recombination and unique restriction site elimination enables extensive manipulation regardless of plasmid size and DNA sequence elements. First, a selectable marker is PCR-amplified with synthetic primers attaching 50-bp homology target flanks for Red/ET recombination and an arbitrary restriction site absent in the substrate plasmid. The resulting cassette is co-electroporated with substrate plasmids in Red/ET-proficient Escherichia coli cells. Following isolation of recombinant plasmids, linear nonselectable DNA replaces the cassette and introduces the desired mutation(s) in a second Red/ET recombination step. Upon selective digestion of parental plasmids and retransformation, a 38% mutation efficiency was achieved using a synthetic 97-nucleotide oligonucleotide to cure a 17-bp deletion within lacZα of pUC19 (2,686 bp). A PCR fragment was used with similar efficiency to co-replace mouse Cdkn1b codons 9 and 76 in gene-targeting vector pGTC (13,083 bp).
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Short Technical Reports and tetracycline (Tc) were added to final concentrations of 100, 50, 50, and 3 µg/mL, respectively. X-gal (5-bromo-4-chloro-3-indolyl-β-D-galacto-pyranoside; 40 µg/mL) was added to the corresponding plates. Electrocompetent cells for retransformation were prepared as described (18) .
DNA manipulations
Standard protocols were used for conventional in vitro cloning (19) . HPLCpurified oligonucleotides were obtained from BioSpring (Frankfurt, Germany); drug R cassettes A002 (km R ) and A006 (cm R ) were purchased from Gene Bridges (Heidelberg, Germany). PCR reactions were performed with Triple Master DNA polymerase according to the manufacturer's recommendations (Eppendorf, Hamburg, Germany). Prior to electroporation, PCR fragments were treated with DpnI and purified using the MinElute PCR purification kit (Qiagen, Hilden, Germany). The QIAprep Spin Miniprep Kit (Qiagen) was used for plasmid isolation. DNA sequencing was done at GATC Biotech (Konstanz, Germany). λ-Red recombination was performed as described by Gene Bridges with minor modifications. In brief, 1.4 mL Red/ET-proficient culture was grown at 30°C to an OD 650 nm of ∼0.3. Transient expression of the pRed/ET-encoded red genes was induced by adding 50 µL of 10% (w/v) L-arabinose followed by a temperature increase to 37°C. After 25 min, the cells were washed twice with ice-cold 10% (v/v) glycerol and electroporated with DNA in a chilled 1-mm cuvette.
Target plasmids
The target plasmids used in this study are derivatives of high-copy number plasmid pUC19 whose replication origin (ori) initiates mostly unidirectional DNA replication (20) . To construct reporter plasmid pUCΔ 17 ( Figure 1A ), pUC19 was SmaI/HincII-digested and religated. The 17-bp deletion rendered lacZα inactive ( Figure 1A ) and resulted in a loss of unique BamHI, XbaI, and SalI sites, which was confirmed by sequencing.
pGTC was previously engineered for mouse embryonic stem cell recombination. In brief, a TGG-to-TAG point mutation (bold indicates mutation location) of the mCdkn1b codon 76 was introduced into BAC RP23-153J19 using rpsL-based counter-selection. To achieve pGTC, a 10,446-bp BAC fragment comprising the introduced point mutation was cloned into a pUC19-derived plasmid (2,637 bp).
Results and discussion
km R -LS construction and targeting of substrate plasmid pUCΔ 17 Primers LS1 5′/3′ were designed to PCR-amplify km R cassette A002 with 50-base tails homologous to the region flanking the 17-bp deletion within pUCΔ 17 . In addition, primer LS1 3′ introduced KpnI, PmeI, PacI, and NotI recognition sites in km R -LS (1,057 bp, Figure 1A ). Upon co-electroporation of 100 ng km R -LS and 10 ng pUCΔ 17 into Red/ET-proficient cells, we obtained ∼300 Ap R +Km R transformants. No colonies were observed on selective plates without arabinose induction of the red machinery. The migration patterns of potential pUCΔ::km R -LS (3,627 bp) isolated from six representative clones were analyzed by gel electrophoresis ( Figure 1B ). As expected for multiplecopy number plasmids, we observed mixed populations of parental and recombined plasmids as well as higher molecular weight species (15) (16) (17) . Lanes 3 and 6 were found to contain supercoiled plasmids of mainly monomeric state, which appeared as a single ∼3.6-kb band following PmeI digestion ( Figure 1B ). HS996 cells were retransformed with 10 ng of this DNA and correct km R -LS integration was confirmed by sequencing.
Reconstitution of pUC19 by oligonucleotide-directed recombination
The oligonucleotide +17, complementary to the lagging strand of pUC19, was designed to have the 17 bases 'missing' in pUCΔ 17 flanked by an additional 40 bases up-and downstream of the deletion site. We co-electroporated 5 pmol oligonucleotide +17 and 10 ng of pUCΔ::km R -LS into Red/ET-proficient HS996. The cells were incubated for 1 h in 1 mL LB at Figure 1 . Reconstitution of pUC19. (A) km R cassette A002 was PCR-amplified with primers LS1 5′/3′ (small horizontal arrows) which attached 50-base tails homologous to the respective plasmid target sites (blue). In addition, reverse primer LS1 3′ introduced KpnI, PmeI, PacI, and NotI linearization sites (LS, red). Starting from pUCΔ 17 , pUC19 was restored in a two-step recombineering approach. In the first step, km R -LS (1,057 bp) was inserted at the lacZα deletion site, resulting in pUCΔ::km R -LS. Subsequently, km R -LS was replaced by oligonucleotide +17 (97 nucleotides), rendering lacZα active in a small subset of plasmids. Recombinant pUC19 plasmids lack the KpnI, PmeI, PacI, and NotI recognition sites and were ≥500-fold enriched by selective PmeI or NotI linearization of parental plasmids and retransformation. The relative position of LS sites and the diagnostic XbaI site are indicated. Photo, functional analysis of pUC19 restoration. Colonies from E. coli pUCΔ 17 (a), E. coli pUCΔ::km R -LS (b), and recombined E. coli pUC19 (c) were restreaked on a Ap+X-gal indicator plate. E. coli pUC19 displayed a blue pigmentation caused by restoration of plasmid-borne lacZα .The photo was taken after overnight incubation at 37°C. (B) Analysis of native and PmeI-digested pUCΔ::km R -LS candidates isolated from 6 representative Km R +Ap R clones. As described previously (15) (16) (17) , mixed populations of parental and recombined plasmids as well as higher-molecular weight species were observed following recombination. Lanes 3 and 6 displayed mainly supercoiled monomers which appeared as single bands of the expected size (3,627 bp) following PmeI treatment. (C) Restriction analysis of recombinant pUC19. All plasmids isolated from seven representative LacZ + revertants (Ap R +Km S ) appeared in monomeric state (native, lanes 1-7). Correct oligonucleotide targeting was confirmed by the presence of an XbaI site which was used to linearize recombinant pUC19 (XbaI, lanes 1-7) whereas original pUCΔ 17 37°C and subsequently used to inoculate a 10-mL overnight culture supplemented with Ap. Plasmid DNA (250 ng) isolated from the overnight culture was treated with PmeI (10 U in 20 µL, 2 h at 37°C) to selectively linearize parental plasmids, which thereby lose their ability to efficiently transform E. coli (21) . A control sample without restriction enzyme was incubated under otherwise identical conditions. The samples were heat-inactivated and 25 ng DNA was used to retransform HS996 cells.
PmeI treatment resulted in a ∼580-fold reduction of Ap R transformants. Most notably, 38% of the clones obtained from PmeI-treated plasmids appeared blue on X-gal indicator plates (Table 2) , implying restoration of lacZα. A similar result was achieved by using NotI for the selective elimination of parental plasmids (data not shown). We restreaked 50 blue colonies on Ap+Km plates. No growth was observed following overnight incubation at 37°C, which demonstrates the complete loss of parental pUCΔ::km R -LS plasmids since a single km R cassette is sufficient for HS996 to grow at 50 µg/mL Km (data not shown). For seven randomly picked blue clones, pUC19 integrity was inspected by gel electrophoresis ( Figure  1C) . In all cases examined, the plasmids appeared as monomers and contained the restored XbaI site as documented by enzymatic linearization, whereas the original plasmid pUCΔ 17 was immune to XbaI cleavage.
Co-generation of scattered point mutations in mouse targeting vector pGTC To demonstrate the seamless modification of medium-to large-size plasmids without visual color discrimination, we simultaneously introduced two point mutations separated by 200 bp in plasmid pGTC (13,083 bp; Figure 2A ). Primers LS2 5′/3′ were designed to amplify cm R cassette A006 with 50-base tails homologous to the pGTC region flanking codon 9 to 76 of mCdkn1b coding sequence. In addition, LS2 3′ introduced ApaI, PmeI, AscI, and EcoRV recognition sites 3′ of the cm R gene (Figure 2A) . Upon co-electroporation of 100 ng cm R -LS (863 bp) and 10 ng pGTC into Red/ET-proficient cells, we obtained 112 Cm R transformants. No colonies were observed on selective plates without arabinose-induction of the recombination machinery. Plasmids were isolated from 10 transformants and migration patterns were analyzed by gel electrophoresis ( Figure 2B ). We found 8 clones to appear mainly as monomers. ScaI digestion revealed migration patterns characteristic for various populations of parental and recombinant plasmids. We retransformed HS996 with 10 ng of mainly monomeric recombinant plasmid DNA to separate pGTC::cm R -LS from traces of parental pGTC and higher-weight species.
Primers PM 5′/3′ were used to PCR-amplify a 412-bp fragment from original BAC RP23-153J19 ( Figure  2A) . PM 5′ introduced a GGG-to-AGG point mutation corresponding to codon 9, whereas the codon exchange at position 76 (TAG-to-TGG) reflected a reversion to the BAC-encoded wild-type situation. Codons 9 and 76 of the modifying DNA were flanked by 50-bp and 156-bp tails homologous to mCdkn1b. Thus, the PCR fragment enabled us to co-introduce codon exchanges at position 9 and 76 of pGTC-borne mCdkn1b. We co-electroporated 100 ng PCR product and 10 ng pGTCΔ::cm R -LS into Red/ET proficient HS996. Afterwards, the cells were treated as described for the pUC19 reconstitution except that overnight incubation was performed in the presence of Ap+Km and ApaI (10 U) was used for USE. Following ApaI digestion we obtained 20 colonies on Ap+Km plates, while ∼10,000 transformants were received without enzymatic treatment. Nine out of the 20 clones were found to be Cm S , implying loss Figure 2C ). Sequencing confirmed the expected GGG-to-AGG (codon 9) and TAG-to-TGG (codon 76) exchanges (Figure 2A ). Based on previous work (15-17,22) we have developed a recombineering protocol to introduce seamless mutations onto high-copy number plasmids. As described here, two rounds of recombination enabled precise and scarless plasmid manipulations (i.e., the restoration of pUC19 by oligonucleotide +17 and the co-introduction of scattered point mutations in gene-targeting vector pGTC. While we have focused on ColE1-based plasmids in this study, our unpublished results show that this method is also applicable for the manipulation of p15A-based vectors.
Using genetically stable E. coli HS996, we expected the plasmid recombination frequency to be in the range of their BAC and chromosomal counterparts (i.e., ∼10 -3 -10 -4 ) (9). Strain and/or culturing condition-specific CS markers like rpsL, sacB, thyA, and tolC have been successfully used to identify recombinant singlecopy replicons where the counterselective cassette was replaced by markerless DNA (11) (12) (13) (14) . However, we expected these CS markers to cause problems in plasmid recombineering where the bulk of transformants contain plasmid mixtures (15) . For that reason, we have applied a rational USE approach to selectively eliminate parental plasmids in vitro. Deng and Nickoloff originally combined USE and SDM (8) . The novelty of using USE here is that any restriction site a priori absent in the original vector can be chosen for plasmid linearization. This approach is of broad application because a 'non-cutting' enzyme is usually available even for a large plasmid. Thus, a site-specific drug R -LS cassette can be designed, PCR-amplified, and introduced in almost any substrate plasmid, which then gets tagged for seamless downstream manipulation.
We found the isolation of monomeric drug R -LS encoding plasmids to be critical for the success of the whole strategy. Co-electroporation of substrate plasmids and modifying DNA minimized the formation of multimers and resulted mainly in populations of monomeric parental and recombinant plasmids as displayed by gel electrophoresis (Figures 1B, 2B ). In contrast, targeting resident pUCΔ 17 with km R -LS yielded higher weight molecules-most likely dimers-as the dominant species (data not shown). Thus, the isolation of monomeric drug R -LS plasmids requires careful monitoring of the plasmid topology and retransformation to purify desired monomeric molecules away from parental plasmids and multimers.
Targeting pUCΔ::km R -LS and pGTC::cm R -LS with linear ss or ds modifying DNA was followed by USE. This step is directly correlated to the success of mutagenesis because linear plasmid is about 10 3 -10 4 times less efficient in electroporating E. coli than its corresponding circular plasmid (21) . Hence, recombinant plasmids were enriched ≥500-fold by selective PmeI, NotI, or ApaI digestion and retransformation. Although we did not achieve a quantitative elimination of parental pUCΔ::km R -LS plasmids, our results indicate that the vast majority of blue transformants obtained on Ap+X-gal plates were LacZ + revertants which contained monomeric recombinant pUC19 and did not harbor parental plasmids ( Figure 1C) . No multimers were observed after the second recombination Upon targeting pUCΔ::km R -LS with oligonucleotide +17, PmeI-digested or undigested plasmid DNA (25 ng) isolated from Ap R cells was used to retransform HS996. LB plates supplemented with Ap and X-gal were used to determine the number of transformants following overnight incubation at 37°C. The values are the mean and standard deviation of three independent digestion and transformation experiments. Cells transformed with undigested plasmids were diluted 1:1000 prior to plating.
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Short Technical Reports step ( Figures 1C and 2C ), which suggests that higher-weight species still contain a parental allele and are subject to USE. Thus, we divided the number of blue colonies by the total number of colonies (Table 2) to calculate a recombination frequency of ∼7 × 10 -4 for the oligonucleotide-directed reconstitution of pUC19.
Since there is no selection pressure on the mutagenic +17 oligonucleotide, this reflects an objective indication of the plasmid recombineering process in genetically stable cells. Recombinant pGTC* (Figure 2 ) was obtained with similar efficiency which demonstrates that no visual discrimination is required to rapidly identify desired plasmids.
Conclusions
Plasmid recombineering opens access to an extensive mutational spectrum because this method is suitable to introduce single or multiple scarless modifications (insertion, deletion, replacement) in a wide range of sizes. In contrast, SDM methods usually tolerate only a few mismatches in the mutagenic primer. Furthermore, several protocols depend on methyl-directed mismatch repair (MMR)-deficient host strains to prevent in vivo repair of the unmethylated newly synthesized DNA strand (23, 24) . The drawback here is that silencing the MMR system significantly reduces the replication fidelity (25) . Our method does not require in vitro amplification of the plasmid backbone or the use of a mutagenic E. coli host strain. Thus, even large plasmids can be manipulated without the risk of accumulating random mutations. The superior flexibility of recombineering also has definite advantages for the manipulation of small plasmids, which are accessible by existing methodology. For example, plasmids designed for heterologous protein production and purification (e.g., pQE and pET series) can be directly targeted with PCR-amplified or synthetic genes that thereby replace the multiple cloning site. This is likely to provide one or more restriction enzyme candidates for the elimination of empty parental vectors. Since the base-precise join points of the recombinant plasmid are defined by the arbitrary sequence of the target gene flanks, plasmid recombineering-which dispenses with the need for intermolecular ligation-overcomes problems associated with in-frame cloning and the addition of unwanted 5′ or 3′ codons.
Given its flexibility and relative ease, the method reported here should prove to be a welcome alternative to conventional methods of plasmid manipulation.
